News Releases

Three State and Federal Grants Fund Campaign to Encourage COVID-19 Vaccination Among People with Intellectual and Developmental Disabilities
Albert Einstein College of Medicine Awarded $5 Million for Research on Intellectual and Developmental Disabilities
Einstein Named a Top New York State Employer by Forbes

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Sanjeev Gupta

Sanjeev Gupta, M.B.,B.S., M.D.

Area(s) of expertise: Stem cell researchCell therapyGene therapy

Dr. Gupta is a pioneer in the development of cell therapy – treating disease by introducing healthy cells into the body.  He has discovered various mechanisms for coaxing transplanted cells to attach to… Learn more

Einstein in the News

ABC News
Anxiety, Depression Fluctuated with COVID-19 Waves: Study

Panagiota Korenis, M.D., comments about anxiety and depression during the COVID-19 pandemic and notes the importance of caring for oneself and seeking treatment for mental health issues. Dr. Korenis is associate professor of psychiatry and behavioral sciences at Einstein.

More coverage on Dr. Korenis

How the Risk of COVID-19 for Kids Compares to Other Dangers

Betsy Herold, M.D., says there is no evidence that the risk of COVID-19 in children has changed due to the Delta variant. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and the Children's Hospital at Montefiore and the Harold and Muriel Block Chair in Pediatrics at Einstein.

More coverage on Dr. Herold

PBS Newshour
The Cannabis Question

In a NOVA documentary, Chinazo Cunningham, M.D., M.S., talks about unresolved questions regarding which patients may benefit from using cannabis and the negative effects of incarcerating people for drug use. Dr. Cunningham is clinical professor of medicine, of family and social medicine, and of psychiatry and behavioral sciences at Einstein. (Excerpts with Dr. Cunningham at 10:13, 40:37, and 42:58.)

More coverage on Dr. Cunningham


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog